返回
Infant Bacterial Therapeutics AB (publ)（IFTBF）價格
IFTBF 股價走勢圖
IFTBF 收益
Infant Bacterial Therapeutics AB (publ)
$5.47
14.43%
$0.68
截至今日：Jan 29, 13:13:08 GMT-5
Earnings FAQ
IFTBF 最近的每股盈餘與預期相比如何？
Infant Bacterial Therapeutics AB (publ) IFTBF 上一季度的收入表現如何？
Infant Bacterial Therapeutics AB (publ) 的收入預期是多少？
Infant Bacterial Therapeutics AB (publ) 的盈利品質評分是多少？
Infant Bacterial Therapeutics AB (publ) 何時發布財報？
Infant Bacterial Therapeutics AB (publ) 的預期收益是多少？
Infant Bacterial Therapeutics AB (publ) 是否超出收益預期？
關鍵數據
前收市價
$4.78
開盤價
$5.47
當日範圍
$5.47 - $5.47
52週區間
$4.78 - $8.2
交易量
--
平均成交量
1.0K
每股盈餘 (TTM)
--
股息收益率
--
市值
$71.2M
什麼是 INFANT BACTERIAL THERAPEUTICS A？
Infant Bacterial Therapeutics AB is a clinical stage pharmaceutical company, which engages in the development of drugs for the treatment of rare diseases affecting premature infants. The company is headquartered in Stockholm, Stockholm and currently employs 10 full-time employees. The company went IPO on 2016-03-29. The firm develops drugs that meet the needs of the premature infant. The Company’s focus is on clinical development of IBP-9414, a drug candidate containing Lactobacillus reuteri, in the prevention of necrotizing enterocolitis (NEC), a fatal disease that affects premature infants.